Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Biogen
Biotech
Moderna
AbbVie
Celltrion
Gilead Sciences
Topics

Advertisement

Advertisement

Biogen

Share

Top Latest Popular

In the last half hour

Biogen (BIIB) Surges 5.3%: Is This an Indication of Further Gains? Zacks 13:29

Yesterday

DHL Supply Chain and Biogen expand health logistics partnership in Türkiye The Stat Trade Times 15:49 Thu, 22 Oct

Wednesday

The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics Zacks 15:16 Wed, 21 Oct

Advertisement

Advertisement

Monday

Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week Biogen (Press Release) 12:40 Mon, 19 Oct

In the last month

Biogen-backed Estuary nabs $93M for kidney disease gene therapy BioPharma Dive 13:45 Fri, 16 Oct

Biogen Preliminary Third Quarter 2026 Acquired In-Process Research and Development Charges Biogen (Press Release) 22:34 Thu, 15 Oct

Teen begs Andy Burnham for life-extending drugs as mum helplessly forced to watch decline The Mirror 15:20 Thu, 15 Oct

Local life sciences scene ‘can’t just rest on our laurels,’ Biogen CEO warns Boston Globe 14:18 Tue, 13 Oct

Biogen announces phase 2 data for cutaneous lupus erythematosus PMLiVE 13:16 Thu, 08 Oct

Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report? Zacks 18:17 Tue, 06 Oct

Biogen Reports 52-Week Litifilimab Data In Cutaneous Lupus; Phase 3 Readout Ahead RTT News 17:17 Fri, 02 Oct

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus Biogen (Press Release) 16:21 Fri, 02 Oct

Biogen Opens Enrollment in Phase 3 Studies of Salanersen in SMA Rare Disease Advisor 20:02 Wed, 30 Sep

Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs? Zacks 16:52 Mon, 28 Sep

Advertisement

Advertisement

Advertisement

About our Biogen News

Biogen is an American multinational biotechnology company that specialises in treatment of neurological diseases.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna